ArticleScientific reports2017

Aldose reductase inhibitor increases doxorubicin-sensitivity of colon cancer cells and decreases cardiotoxicity.

Himangshu Sonowal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.